Watch and track your favorite playlist.
Curated by: Ben Bikman (139 videos)
📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: GLP-1 is often described as an insulin-stimulating hormone, but in real meal settings its main role is to slow gastric emptying and reduce the need for insulin. Chronic hyperinsulinemia may progressively silence the gut’s GLP-1-producing L-cells, creating a vicious cycle in which high insulin lowers GLP-1, and low GLP-1 drives even higher insulin. Summary: GLP-1 has become one of the most talked-about hormones in modern medicine, largely due to the rise of GLP-1 receptor agonist drugs for weight loss. In this lecture, Dr. Ben Bikman shifts the focus from how GLP-1 affects insulin to the overlooked reverse question: how insulin affects GLP-1. That shift reveals a deeper metabolic story about how chronic hyperinsulinemia may impair the body’s ability to produce GLP-1 over time. Dr. Bikman first clarifies a key misconception. While GLP-1 can stimulate insulin under artificial conditions, in a real meal its dominant role is to slow gastric emptying, suppress glucagon, and reduce the need for insulin. In that sense, GLP-1 functions primarily as an insulin-sparing hormone. This makes the reverse question critical: what happens when the body produces less GLP-1? Evidence shows that insulin-resistant, obese, prediabetic, and type 2 diabetic individuals consistently have a blunted GLP-1 response. Mechanistic studies indicate that chronic exposure to high insulin can make L-cells insulin resistant, reducing their ability to secrete GLP-1 when needed. This may create a vicious cycle: high insulin suppresses GLP-1, low GLP-1 removes metabolic brakes, and the resulting larger glucose and insulin spikes further worsen the problem over time. The lecture reframes GLP-1 deficiency as a potential consequence of chronic hyperinsulinemia rather than an isolated defect. While GLP-1 drugs can bypass this dysfunction and improve outcomes, they do not repair the underlying cause—making long-term strategies that lower chronically elevated insulin levels more fundamental. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-digital-ai-mind In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 01:01 — Introduction: The Overlooked Crosstalk Between Insulin and GLP-1 03:25 — What GLP-1 Does and Why It Matters 07:01 — Does GLP-1 Really Stimulate Insulin? 10:36 — GLP-1 as an Insulin-Sparing Hormone 11:43 — The Bigger Question: Does Insulin Affect GLP-1? 12:48 — Human Evidence: Less GLP-1 in Insulin Resistance and Diabetes 17:31 — The Carb-Specific GLP-1 Blunting Pattern 18:49 — The L-Cell Has an Insulin Receptor 19:57 — Chronic High Insulin Makes L-Cells Insulin Resistant 23:18 — Why Hyperinsulinemia May Silence GLP-1 28:07 — Why GLP-1 Drugs Work Without Fixing the Root Cause 32:41 — The Vicious Cycle: High Insulin, Low GLP-1, More Overeating NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions. #GLP1 #InsulinResistance #Hyperinsulinemia #MetabolicHealth #GLP1Drugs #Semaglutide #Tirzepatide #BloodSugarControl #Insulin #GutHormones #LCells #Type2Diabetes #Prediabetes #GastricEmptying #AppetiteRegulation #WeightLossScience #DrBenBikman #MetabolicClassroom #MetabolismMatters #HealthScience Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884 Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/products/go-bhb Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)